-transparent.png){kind=logo}
Previous work has demonstrated that Lambert-Eaton syndrome (LES) antibodies reduce calcium currents in nonneuronal cells and neurons and reduce the amplitude of extracellularly recorded currents at mouse motor nerve terminals. We compared effects of LES sera on whole-cell currents of cultured nerve and muscle. LES sera more strongly reduced calcium currents in motoneurons than in sensory neurons. Motoneuronal potassium currents were unaffected. The sera minimally affected calcium currents in skeletal and cardiac muscle. In motoneurons, both low voltage-activated (LVA) and high voltage-activated (HVA) components of calcium current were decreased, demonstrating that the sera targeted more than one calcium channel type. The HVA current remaining in LES-treated motoneurons was little affected by micromolar omega-conotoxin MVIIC but was reduced > 70% by micromolar nimodipine. This pharmacological profile contrasts with untreated cells and suggest that LES sera primarily spare L-type currents in motoneurons.
K D García, and
K G Beam
October 1972,
Archives of neurology,
K D García, and
K G Beam
April 1995,
Journal of neurochemistry,
K D García, and
K G Beam
October 1995,
The Journal of physiology,
K D García, and
K G Beam
August 1995,
The Journal of physiology,
K D García, and
K G Beam
January 1994,
Revue neurologique,
K D García, and
K G Beam
April 2018,
Brain and nerve = Shinkei kenkyu no shinpo,
K D García, and
K G Beam
January 1987,
Annals of the New York Academy of Sciences,
K D García, and
K G Beam
January 2003,
Japanese heart journal,
K D García, and
K G Beam
November 1989,
Lancet (London, England),
K D García, and
K G Beam
June 1993,
Annals of the New York Academy of Sciences,
